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OBJECTIVES This study outlines the clinical course, treatment and the late outcome of infants and children
with multifocal atrial tachycardia (MAT).
BACKGROUND Multifocal atrial tachycardia is defined by three distinct P-waveforms, irregular P-P intervals,
isoelectric baseline between P-waves and rapid rate on an electrocardiogram. Several smaller
prior reports have described pediatric patients with MAT, but their long-term outcome has
not been fully assessed.
METHODS The clinical records, echocardiograms and long-term follow-up of patients with MAT were
reviewed and compared to previous reports of MAT.
RESULTS Fourteen boys and seven girls (median age 1.8 months) presented with MAT. At diagnosis,
six patients had respiratory illness, of whom two were critical. Ten were asymptomatic. Seven
patients had structural heart disease (SHD), one of whom died. Four of 15 patients (27%)
with echocardiograms had diminished ventricular function. Ventricular rates were 111 to 253
beats/min (mean 181 beats/min). Median duration of the arrhythmia was 4.9 months (mean
6.7 months). Electrical cardioversion was attempted in 4 patients without success and 15
patients received antiarrhythmic medication. Seventeen patients were followed for a mean of
60 months. Four patients were lost to follow-up. There were no late arrhythmias.
CONCLUSIONS The majority of children with MAT are healthy infants under one year of age; a few may
exhibit mild to life-threatening cardiorespiratory disease. Less often, MAT accompanies
SHD. Mild ventricular dysfunction may be observed in the presence of MAT, but symptoms
are few and resolution is generally complete. Response to antiarrhythmic agents is mixed, and
cardioversion is of no avail. Finally, long-term cardiovascular and developmental outcome
depends principally on underlying condition; for otherwise healthy children, it is excellent.
(J Am Coll Cardiol 2001;38:401–8) © 2001 by the American College of Cardiology
Multifocal atrial tachycardia (MAT), also known as chaotic
atrial rhythm (1), is a rare tachyarrhythmia in infants and
children, accounting for ,1% of supraventricular tachycar-
dia (SVT) seen by the Pediatric Electrophysiology Service
of the University of Michigan Health Systems over the past
20 years. The condition is characterized by the electrocar-
diographic (ECG) finding of: 1) multiple (at least three)
distinct P-wave morphologies; 2) irregular P-P intervals; 3)
isoelectric baseline between P-waves; and 4) ventricular rate
.100 beats/min (2) (Fig. 1). Similar to the more common
forms of SVT seen in childhood, MAT is very rapid—atrial
rates up to 400 beats/min and ventricular rates at 150 to 250
beats/min—but unlike most SVT, it is markedly irregular.
Pauses may be observed following blocked premature atrial
impulses. At high atrial rates, aberrant ventricular conduc-
tion might resemble nonsustained ventricular tachycardia.
Although MAT might be the predominant rhythm for
weeks or months, in most children the irregular, rapid rate
alternates with periods of normal sinus rhythm.
Often, MAT is diagnosed in elderly adults, particularly in
those with chronic obstructive pulmonary disease (3,4).
Although one report associated MAT in children with
hemodynamic collapse, most investigators have described it
as usually causing mild symptoms, and having few sequelae
(1,5–11).
The purpose of this report was to outline the presenta-
tion, course, treatment and late clinical outcome in 21
infants and children with MAT seen at our institution,
along with a summary of similar patients reported else-
where.
METHODS
Using departmental patient databases, 21 patients meeting
the ECG criteria (2) for MAT presenting during the past
two decades were identified. Clinical history, physical ex-
amination and other clinical data were reviewed. Dimin-
ished left ventricular function was defined as a shortening
fraction below 0.30 or a two-dimensional ejection fraction
,0.50 measured by echocardiogram. When those measure-
ments were not obtained, the reported subjective description
of diminished function was used. In 19 patients, follow-up
Holter monitor tracings or electrocardiograms (ECGs)
provided confirmation of complete resolution of MAT.
Particular attention was paid to the follow-up cardiac status,
recurrence of MAT or other arrhythmias, evidence of
cardiac dysfunction or other significant health problems.
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Chi-square analysis was used to evaluate differences between
patient groups. A p value of #0.05 was taken to denote
statistical significance. The Institutional Review Board for
Investigation Using Human Subjects, the University of
Michigan Health Systems, approved this study.
RESULTS
Twenty-one children with MAT were identified: 14 boys
and 7 girls. The median age at diagnosis was 1.8 months
(Fig. 2) (mean 6.5 months; range 0 days to 7.3 years). Six
patients were diagnosed at birth (in 3 patients, irregular
rhythms were observed on fetal monitors), and 20 (95%)
were diagnosed before one year of age. Six patients had
symptoms of intercurrent respiratory illness at diagnosis:
two with nonspecific upper respiratory infections; one with
croup; one with bronchomalacia exacerbated by postopera-
tive atelectasis; one with antigen test-positive respiratory
syncytial virus (RSV) pneumonia, and one respiratory viral
syndrome with myocarditis. These last two were critically ill.
Five other patients had symptoms or signs (e.g., irritability,
tachypnea) possibly due to cardiovascular compromise. Ten
patients (48%) were asymptomatic; the arrhythmia was
identified in three patients during routine examination, one
by a home monitor, three on routine monitoring during
medical procedures, and three on fetal monitors; in one
patient the method of detection is unknown. Among the 15
patients evaluated by echocardiogram, 4 had quantitative
(n 5 3) or subjective (n 5 1) evidence of diminished
ventricular function (Table 1), one of whom had structural
heart disease (SHD). Duration of the arrhythmia, docu-
mented in 19 patients, was a median of 4.9 months (mean
6.7 months; range 8 days to 18.5 months) (Fig. 3). For the
14 patients in whom it could be accurately calculated, the
median interval from detection of an irregular cardiac
rhythm to precise diagnosis was four days (mean 30 days;
range 0 to 238 days).
Although detection of the arrhythmia did not lead to the
diagnosis of SHD in any patient, seven (50%) had anatomic
abnormalities. One had Klippel-Feil syndrome and repaired
tetralogy of Fallot; one had Noonan syndrome and recent
repair of pulmonic stenosis and atrial septal defect; one had
myocarditis; one suffered familial hypertrophic obstructive
cardiomyopathy (HOCM), and one had HOCM, double-
outlet right ventricle and single coronary artery. The patient
who died had heterotaxy syndrome with asplenia, atrioven-
tricular septal defect, pulmonary atresia and growth failure.
He had undergone aortopulmonary shunt placement. The
seventh patient with heart disease was diagnosed with aortic
coarctation 18 months after resolution of MAT. No echo-
cardiogram had been performed, nor had a murmur, differ-
ential pulses or blood pressure gradients been observed at his
initial presentation.
Abbreviations and Acronyms
ECG 5 electrocardiogram, electrocardiographic
HOCM 5 hypertrophic obstructive cardiomyopathy
MAT 5 multifocal atrial tachycardia
RSV 5 respiratory syncytial virus
SHD 5 structural heart disease
SVT 5 supraventricular tachycardia
Figure 1. Electrocardiogram (from patient 6) demonstrating typical characteristics of multifocal atrial tachycardia, with five different P-wave morphologies
(arrows), irregular, rapid atrial rhythm and variable ventricular conduction.
Figure 2. Histogram demonstrating distribution of patients by age at
diagnosis of multifocal atrial tachycardia. Most children diagnosed with
multifocal atrial tachycardia are infants.
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Fifteen patients had echocardiograms as part of their
evaluation; 11 demonstrated normal cardiac function and
chamber dimensions. Of these 11, 3 had normal ventricular
function and cardiopulmonary symptoms, 4 patients had
abnormal function but no symptoms, and 4 had normal
function and no symptoms. Of the five patients who had
both SHD and an echocardiogram while in MAT, one
demonstrated diminished function. No relationship was
seen between diminished left ventricular function and car-
diorespiratory symptoms (x2 5 1.0; p 5 0.31). The mean
ventricular rate at diagnosis was 181 beats/min (range
111–253 beats/min). There was no significant difference in
the mean ventricular rate between patients with and without
diminished left ventricular function (176 vs. 196 beats/min;
p 5 0.45).
Treatment, initiated either at the referring institution or
at our own institution, is summarized in Table 2. Fifteen
patients (71%) received at least one antiarrhythmic agent.
Four patients underwent attempts at direct current or
overdrive pacing cardioversion, but without success. Ven-
tricular rate-slowing effects of agents such as digoxin were
noted but could not be verified.
Follow-up data were available for 17 patients; mean
follow-up interval was 60 months (range 8 to 216 months).
Four patients were lost to follow-up. Three of the four
children (except for Patient 16, with myocarditis) with
abnormal ventricular function in the presence of MAT had
normal function upon repeated imaging after cessation of
MAT. In the follow-up group (n 5 17), three patients are
taking medication; two patients with HOCM are taking
verapamil (Patients 12, 17) and one (Patient 10) is taking
digoxin for diminished right ventricular function after repair
of tetralogy of Fallot. The one death occurred in the patient
with heterotaxy syndrome (Patient 21) while hospitalized
for respiratory distress. Receiving digoxin and amiodarone
and nearing discharge, he developed progressive, severe
bradycardia during feeding and could not be resuscitated.
Monitor tracings demonstrated sinus rhythm for six days
prior to his death. In the follow-up group, three patients
(Patients 5, 10, 20; 14%) have delayed psychomotor devel-
opment; of these, one (Patient 20), has Noonan syndrome
and two (Patients 5, 10) are hearing-impaired. All other
patients are alive and well, without any cardiovascular
symptoms, and at an age-appropriate developmental level at
last follow-up. The 16 living patients in the follow-up group
are free of tachyarrhythmia.
When the published reports of MAT in children (Table
3) are considered together with those in this report (n 5
105), mortality was 11% during the period of follow-up. In
the 33 (31%) with heart disease, mortality was 24% (8 of
33), and in those without heart disease mortality was 4% (3
of 72; x2 5 9.7; p 5 0.001). Male patients (n 5 68), who
comprised 65% of the total population, had a mortality rate
similar to that of female patients (x2 , 0.01; p 5 0.99).
DISCUSSION
This report of 21 children with MAT (also known as
chaotic atrial rhythm or chaotic atrial tachycardia) confirms
previous studies with regard to their age range, clinical
context and outcome and extends the duration of follow-up
(1,5–9,12). Seen in a range of clinical settings in our study,
MAT was self-limited and nonrecurring. Of the 19 children
in whom arrhythmia duration was known, 10 reverted
permanently to sinus rhythm within five months (Fig. 3).
Sixteen of 17 patients demonstrated no cardiac symptoms or
arrhythmia in long-term follow-up (mean 60 months). The
one exception is Patient 10, who has not had a tachyar-
rhythmia but has required a pacemaker for transient com-
plete heart block observed during anesthesia induction.
Mortality. Yeager et al. (11) reported on four infants present-
ing with MAT, three of whom died two to five months after
diagnosis. One infant had poorly controlled ectopic atrial
tachycardia prior to the diagnosis of MAT, marked mitral
valve abnormality and pathologic findings of myocarditis at
autopsy. One was diagnosed with MAT at six weeks of age,
but had normal ECGs two weeks later. He died in his crib at
seven months. The third patient who died had multiple
craniofacial anomalies and tetralogy of Fallot. At three months
of age he developed respiratory distress following a feeding,
and died before an ECG could be obtained. Chest radiograph
demonstrated bilateral lung infiltrates. Although the presence
of MAT could not be confirmed at the time of death in two of
these three patients, the investigators postulated that the
arrhythmia might have been related to these deaths. One of
our patients (Patient 6), who had severe respiratory insuffi-
ciency but normal cardiac function by echocardiogram, re-
quired cardiopulmonary resuscitation during his illness but
survived. The three-month-old boy in our series with complex
heterotaxy syndrome (Patient 21) represents the sole death in
our series. The severity of this patient’s anatomic defect, the
absence of arrhythmia at the time of his death and the
infrequency of death in reports of MAT especially in the
absence of SHD suggest that MAT per se is not strongly
linked to patient mortality. Of the 105 reported patients, the
significantly higher mortality in those with SHD than in those
without (24% vs. 4%) underscores the important influence of
the underlying heart disease. Similarly, 14 of our 21 patients
had anatomically normal hearts (i.e., neither acquired nor
congenital heart disease), suggesting that MAT does not
require an abnormal heart for its initiation or persistence.
Electrophysiologic mechanism. The electrophysiologic
mechanism or mechanisms underlying MAT remain un-
known. Most investigators have postulated that the atrium
is activated at a rapid rate by impulses from multiple
automatic foci. This accounts for the many P-wave mor-
phologies, their irregularity and their frequency (Figs. 1 and
4A,B). Additionally, as with ectopic atrial tachycardia,
which arises from a single automatic focus, it would explain
MAT’s poor response to cardioversion. In a dog model,
rapid stimulation of the right vagal nerve produced multi-
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focal atrial depolarizations and sinus pauses, raising the
possibility that autonomic influences might be responsible
for MAT (13). Another possible mechanism is that the
varied P-wave morphologies seen in MAT may not repre-
sent impulses of multifocal origins, but rather varied prop-
agation of impulses originating at a single focus. Bevilacqua
et al. (14) recently described a four-month-old with MAT
(the investigators’ term was “chaotic atrial rhythm”) and
severely depressed ventricular function. Successful radiofre-
quency ablation of the arrhythmia resulted from application
of energy to a single site at the posterior margin of the fossa
ovalis in the right atrium. The investigators further noted
that at times this arrhythmia exhibited minimal isoelectric
baseline between the P waves, and thus may have more
closely resembled atrial fibrillation. Recordings suggestive of
atrial fibrillation in the context of MAT have been reported
(1,5,6,15) and were seen in one of our patients (Fig. 4C). This
raises the possibility that MAT may occasionally induce atrial
fibrillation in a manner similar to the “focal” atrial fibrillation
described in adults by Haı¨ssaguerre et al (16).
MAT and respiratory infection. A number of patients
with MAT have been diagnosed in the context of a
respiratory infection, suggesting a possible link. The asso-
ciation between SVT and viral illness was first proposed
several decades ago (17). However, little evidence is avail-
able to support a causal relationship. Terasaki et al. (18)
described a variety of supraventricular and ventricular tachy-
arrhythmias in a murine coxsackie B3 myocarditis model.
Furthermore, Donnerstein et al. (15) described eight
patients with respiratory syncytial virus (RSV) and atrial
arrhythmias; four were diagnosed with automatic atrial
arrhythmias versus chaotic atrial tachycardia. In the re-
view by Wu et al. (9), 17 of 22 patients with MAT had res-
piratory illnesses. In our study, a significant number (29%)
had intercurrent respiratory illness. Finally, the well-known
association of MAT and chronic obstructive pulmonary
Table 1. Patient Characteristics
Patient No. Age Gender
Symptoms While in
Tachycardia
Medical History, Intercurrent Illnesses,
Chronic Pathology
1 3 mo F Rhinorrhea Ex-23 wk triplet, mild URI
2 1 mo M None None
3 1 mo F None None
4 2 mo M Increased fussiness Diarrhea 3 2 days, afebrile, mild URI
5 Newborn M None Prematurity, dysmorphic, deaf, growth and
developmental delay
6 2 mo M Respiratory distress,
thick rhinorrhea
Saggital sinus thrombosis at birth, RSV
pneumonia, respiratory arrest
7 Newborn F None None
8 3 mo M Mild irritability and
conqestion
Mild URI, normal development
9 Newborn M Tachypnea Coarctation, verrucous nevus, small CCAM
10 11 mo M Stridor with mild-moderate
respiratory distress
Klippel-Feil syndrome, repaired TOF, Sz,
developmental delay, croup
11 2 mo M None History of urgent cesarian section for
arrhythmia
12 Newborn F Hypotonia, tachypnea Birth asphyxia due to shoulder dystocia,
HOCM, DCRV, ASD, single RCA,
Noonan syndrome
13 1 mo F None None
14 Newborn F None None
15 4 mo M None None
16 3 mo M Marked respiratory distress,
rhinorrhea, fever
Myocarditis, URI progressing 2 weeks
before presentation
17 7 yr F None Familial HOCM
18 1 mo M None None
19 Newborn M Fussiness None
20 8 mo M Tachypnea Noonan syndrome, ASD, PS, s/p valvulotomy,
bronchomalacia, pleural effusion, LUL
atelectasis
21 9 days M Irritability, variable perfusion,
mild hypotension
Heterotaxy, AVSD, pulmonary atresia,
TAPVR, single ventricle, s/p central shunt,
PA augmentation
ASD 5 atrial septal defect; AVSD 5 atrioventricular septal defect; CoA 5 coarctation; CCAM 5 congenital cystic adenomatoid malformation; DCRV 5 double-chamber right
ventricle; EF 5 ejection fraction; fx 5 function; HOCM 5 hypertrophic obstructive cardiomyopathy; LUL 5 left upper lobe; LV 5 left ventricle; LVEDD 5 LV end diastolic
dimension; LVSD 5 LV systolic dimension; MR 5 mitral regurgitation; n/a 5 information not available; PA 5 pulmonary artery; PI 5 pulmonary insufficiency; PS 5
pulmonary stenosis; RCA 5 right coronary artery; RSV 5 respiratory syncytial virus; RV 5 right ventricle; SF 5 shortening fraction; s/p 5 status post; Sz 5 seizure disorder;
TAPVR 5 total anomalous pulmonary venous return; TOF 5 tetralogy of Fallot; TR 5 tricuspid regurgitation; URI 5 upper respiratory infection.
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disease in the adult patient suggests more than a coinciden-
tal relationship. Pulmonary disease may influence the elec-
trophysiologic properties of the heart by such mechanisms
as release of pulmonary inflammatory cytokines, the indirect
effects of altered pulmonary mechanics and gas exchange, or
direct myocardial inflammation, altering myocyte mem-
brane properties and resulting in abnormal automaticity. As
both our experience and the experience of others have
shown, electrical cardioversion does not convert MAT to
sinus rhythm, thus providing additional support for an
automatic mechanism.
Incidence. The incidence of MAT in children is unknown,
but it appears to be low. As suggested by our ten (48%)
asymptomatic patients, there may be individuals who de-
Figure 3. Kaplan-Meier analysis of duration of arrhythmia for the 19
patients in whom it was known. Dotted lines indicate the 95% confidence
intervals. Fifty percent of patients reverted to sinus rhythm within five
months. MAT 5 multifocal atrial tachycardia.
Table 2. Attempted Treatment for MAT
Antiarrhythmic medication 15/21
Digoxin 14
Propranolol 4
Quinidine 3
Amiodarone 1
Esmolol 1
Lidocaine 1
Procainamide 1
Cardioversion 4/21
Synchronized direct current 3
Overdrive pacing 3
MAT 5 multifocal atrial tachycardia.
Table 1. Continued
Ventricular Rate
(beats/min) Echocardiographic Result Current Health Status
Arrhythmia
Duration (days)
Duration of
Follow-up
253 NI function Normal 148 5 yr 4 mo
208 SF 35%, EF 55% Normal 291 19 mo
136 SF 31%, “dilated heart” Normal n/a n/a
242 SF 24% Normal 43 38 mo
125 Normal Developmental delay, deaf 555 54 mo
200 Normal Lost to follow-up n/a 3 yr 9 mo
175 None Normal 26 5 yr 4 mo
132 EF 57% Normal 192 8 yr 6 mo
190 Normal ventricular function Normal 360 10 yr 11 mo
146 None PI, decreased RV fx,
bifascicular block, deaf,
pacemaker
112 10 yr 10 mo
111 None Normal 102 21 mo
155 None Asymptomatic, followed for
HOCM
9 17 yr 9 mo
179 LVEDD 95 percentile,
LVSD 95 percentile
Lost to follow-up 110 15 mo
210 Normal Lost to follow-up n/a n/a
150 Normal Normal 69 n/a
146 Dilated, poorly contractile LV Normal 20 20 mo
230 HOCM, SF 51%, EF 88% Asymptomatic, followed for
HOCM
357 23 mo
None Normal 332 36 mo
170 None Normal 8 24 mo
210 Normal LV and RV fx,
PS with 45 mm gradient
Normal n/a 2 mo
250 Normal LV fx, 31 MR,
dilated left atrium, 11 TR
Deceased 244 n/a
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velop this arrhythmia and revert to sinus rhythm before it is
detected. Southall et al. (19) prospectively evaluated ECGs
of 3,383 normal newborns. Those with abnormalities un-
derwent repeated 24-h Holter testing over their first three
years of life. Two of the 3,383 newborns had MAT, both
asymptomatic at three years of age. These data would
suggest an incidence in neonates of 0.02%.
Therapy. There is no standard, proven therapeutic ap-
proach to patients with MAT. Wu et al. (9) saw little
benefit to a variety of antiarrhythmic agents early in their
experience, and they refrained from treating their later
patients. The mechanism of the arrhythmia was initially
believed to be re-entrant in four of our patients, and
cardioversion was attempted (Table 2). It was uniformly
unsuccessful, a hallmark of this arrhythmia. Digoxin, the
most commonly used medication in our and other series,
was given to slow the ventricular response.
The use of several newer antiarrhythmic agents has been
described for children with MAT, with mixed results. In
two series describing the use of sotalol for various pediatric
SVTs, two out of three patients with MAT did not respond
(20,21). Although encainide is no longer available, response
to encainide in five children was either “partial(ly) effective”
or “ineffective” (22). A report of two patients suggests that
flecainide may be effective in restoring sinus rhythm (23).
Fish et al. (12) described a response to propafenone within
48 h in five of six patients in whom it was used. Finally,
amiodarone, used in one of our patients, has also been
reported to be effective in MAT, and it is frequently
credited with superior control of the arrhythmia compared
to other agents (8,10,24,25). It should be noted that diverse
effects of antiarrhythmic agents were thought to account for
the poor outcomes of three patients in published series
(Table 3) (8,10,22). Although it remains possible that
diminished left ventricular function seen in some patients
was due to tachycardia-induced cardiomyopathy (26,27),
ventricular rate was not closely linked to functional com-
promise in our patients, and thus does not alone dictate a
need for treatment. Our current practice is to treat under-
lying illness, and, when present, treat echocardiographically
documented ventricular dysfunction with digoxin. Asymp-
tomatic patients are followed without pharmacologic treat-
ment, and medications such as amiodarone are reserved for
symptomatic patients with persistent MAT.
Prognosis. The extended follow-up of this study confirms
prior reported observations of patients with MAT, support-
ing the low mortality and likely good outcome. Long-term
health appears related primarily to underlying conditions.
Patients with normal cardiac anatomy and mild respiratory
illness or no symptoms had spontaneous resolution with
completely normal health status at follow-up. Those with
congenital anomalies or clinical syndromes demonstrated
chronic problems consistent with these diagnoses. Recur-
rence of MAT or other arrhythmias was not observed in any
patient.
Table 3. Published Reports of MAT in children
Authors Ref. Year n
Follow-up
Interval Comment
Farooki and Green 7 1977 2 3 yr First report in children; fetal diagnoses
Bietzke 6 1979 1 14 mo Atrial tachycardia, fibrillation, flutter and MAT in one infant; CHF at
presentation
Bisset et al. 5 1981 10 1–36 mo 1 death
Southall et al. 19 1981 2 3 yr Survey of rhythm in .3,000 newborns
Liberthson and Colan 1 1982 9 3–38 mo Rx predominantly with digoxin, propranolol, quinidine
Wu et al. 9 1984 22 3.5 yr (avg) CHD diagnoses by clinical examination; 3 deaths, 2 with SHD
Yeager et al. 11 1984 4 3–26 mo Report proposing risk with MAT for sudden death; 3 deaths, 2 with SHD
Zeevi et al. 24 1985 1 6 mo Patient with L-TGA. Control achieved after 16 hours of treatment with
amiodarone
Chantepie et al. 25 1986 1 1 yr WPW and MAT, Rx digoxin, disopyramide, and amiodarone
Esterl and Ro¨sel 28 1987 1 8 yr MAT attributed to intrapartum oxytocin; treated with digoxin
Strasburger et al. 22 1988 5 n/a Report of encainide in various childhood SVTs; 1 sudden death attributed to
treatment
Houyel et al. 23 1990 2 6–17 mo Report of flecainide in MAT
Tipple and Sandor 21 1991 2 1–15 mo Report of sotalol in childhood SVTs; 1 MAT case refractory to therapy
Maragne`s et al. 20 1992 1 n/a Report of sotalol in childhood SVTs
Donnerstein et al.* 15 1994 4 1–5 yr Associated various SVT mechanisms with RSV infection
Dodo et al. 8 1995 9 25 mo (avg) Rx procainamide, propafenone and Amio; 2 deaths, both SHD, attributed to
sepsis and OHS
Fish et al. 12 1996 7 1–14 mo Three patients with RSV; propafenone used in 6 of 7 patients
Salim et al. 10 1997 5 1–59 mo One death, attributed to digoxin, encainide, atenolol treatment
Cetta et al. 29 1997 1 None Treatment with digoxin/propranolol
Bevilacqua et al. 14 2000 1 3 mo Successful radiofrequency ablation
Bradley et al. 2001 21 1–18 yr Current study
*Four cases reported as “AAT vs. CAT.”
AAT 5 automatic atrial tachycardia; avg 5 average; CAT 5 chaotic atrial tachycardia; CHD 5 congenital heart disease; CHF 5 congestive heart failure; L-TGA 5
levo-transposition of the great arteries; MAT 5 multifocal atrial tachycardia; n/a 5 not available; OHS 5 open heart surgery; RSV 5 respiratory syncytial virus; SHD 5
structural heart disease; SVT 5 supraventricular tachycardia; WPW 5 Wolff-Parkinson-White syndrome.
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Study limitations. The limitations of this study of
MAT are several. The patient sample is retrospective
and, therefore, biased toward children who had regular
contact with the health care system. For example, monitor-
ing for separate medical issues or at health maintenance
visits identified three patients. Similarly, the closer moni-
toring inherent in the care of patients with heart disease may
lead to preferential recognition of MAT in this group, and
thus a disproportionate representation of them in our and
other reports. Finally, estimates of onset, duration, and
termination of arrhythmia are confounded by variable and
infrequent sampling (i.e., ECGs obtained at follow-up
intervals).
Conclusions. Most children with MAT are infants and are
neither very ill at the onset of the arrhythmia nor adversely
affected by it over the several months it typically persists.
The condition may accompany mild respiratory illnesses or,
less commonly, critical cardiac and pulmonary disease, but
MAT is not a strong indicator of underlying heart disease.
Even in patients without symptoms, mild ventricular dys-
function may be seen echocardiographically, but resolution
is generally complete, without relapse. Response to antiar-
rhythmic agents is limited, although amiodarone shows
promise when control of the rhythm is necessary. Direct
current cardioversion is ineffective and should be avoided.
Management should consist of periodic monitoring and,
when necessary, care directed to underlying comorbid con-
ditions. Finally, long-term cardiovascular and developmen-
tal outcome depends principally on the overall clinical state;
for otherwise healthy children, it is excellent.
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